Osaka — Vax-Before-Travel

Osaka

Fact checked by Robert Carlson, MD

May 13

3 min read

$2.1 Billion Agreement Accelerates Immunotherapies Targeting Toxic Forms of Amyloid Beta

ACI-24.060 is an anti-Abeta active immunotherapy candidate targeting Alzheimer's disease

Alzheimer’s Disease

Fact checked by Robert Carlson, MD

May 9

2 min read

Second-Gen Dengue Vaccine Remains Unavailable in the U.S.

Dengue vaccines are approved in May 2024

Dengue vaccine

Fact checked by Robert Carlson, MD

Nov 23

3 min read

New Dengue Vaccine Resolves Old Dilemma

Qdenga TAK003 vaccine gains FDA priority review

Dengue vaccinations